Provided by Tiger Trade Technology Pte. Ltd.

Gain Therapeutics, Inc.

1.95
+0.05002.63%
Post-market: 1.970.0200+1.03%19:58 EDT
Volume:760.67K
Turnover:1.47M
Market Cap:75.00M
PE:-3.06
High:1.99
Open:1.90
Low:1.87
Close:1.90
52wk High:4.34
52wk Low:1.41
Shares:38.46M
Float Shares:37.12M
Volume Ratio:0.60
T/O Rate:2.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6370
EPS(LYR):-0.8920
ROE:-261.72%
ROA:-86.79%
PB:12.69
PE(LYR):-2.19

Loading ...

BRIEF-Gain Therapeutics Files Prospectus For $35.5 Million Stock Sale - SEC Filing

Reuters
·
Nov 29, 2025

Gain Therapeutics Inc - Files Prospectus for $35.5 Mln Stock Sale - SEC Filing

THOMSON REUTERS
·
Nov 29, 2025

Gain Therapeutics Unveils Preclinical Data Showing GT-02287 Boosts Mitochondrial Function in Parkinson’s Models

Reuters
·
Nov 20, 2025

Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2025

GlobeNewswire
·
Nov 20, 2025

Positive Outlook for Gain Therapeutics: Promising Clinical Trial Results and Stable Financial Health Drive Buy Rating

TIPRANKS
·
Nov 16, 2025

Gain Therapeutics Reports Continued Progress Amid Financial Challenges

TIPRANKS
·
Nov 13, 2025

Gain Therapeutics Q3 EPS $(0.15) Beats $(0.16) Estimate

Benzinga
·
Nov 12, 2025

Gain Therapeutics Q3 EPS USD -0.15

THOMSON REUTERS
·
Nov 12, 2025

Gain Therapeutics Completes Phase 1b Enrollment and Reports Q3 2025 Results

Reuters
·
Nov 12, 2025

Press Release: Gain Therapeutics Reports Financial Results for Third Quarter 2025 and Provides Corporate Update

Dow Jones
·
Nov 12, 2025

Gain Therapeutics Unveils GT-02287 Parkinson’s Therapy Data at Neuroscience 2025

Reuters
·
Oct 30, 2025

Gain Therapeutics to Attend the 2025 Maxim Growth Summit

GlobeNewswire
·
Oct 16, 2025

Gain Therapeutics Inc : Btig Cuts Target Price to $5 From $9

THOMSON REUTERS
·
Oct 16, 2025

Analysts Are Bullish on These Healthcare Stocks: Candel Therapeutics (CADL), Gain Therapeutics (GANX)

TIPRANKS
·
Oct 15, 2025

Gain Therapeutics Price Target Maintained With a $9.00/Share by BTIG

Dow Jones
·
Oct 15, 2025

Gain Therapeutics Price Target Maintained With a $8.00/Share by HC Wainwright & Co.

Dow Jones
·
Oct 13, 2025

Gain Therapeutics Inc reduces board size to seven after Eric Richman resignation

Reuters
·
Oct 10, 2025

Gain Therapeutics to Host Virtual KOL Event Highlighting GT02287 Data for Parkinsons Disease

Reuters
·
Oct 09, 2025

Gain Therapeutics Is Maintained at Buy by Maxim Group

Dow Jones
·
Oct 08, 2025

Oppenheimer Remains a Buy on Gain Therapeutics (GANX)

TIPRANKS
·
Oct 07, 2025